These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16964180)

  • 1. An extended pelvic lymph-node dissection should be performed in most patients if radical prostatectomy is truly indicated.
    Burkhard FC; Schumacher MC; Studer UE
    Nat Clin Pract Urol; 2006 Sep; 3(9):454-5. PubMed ID: 16964180
    [No Abstract]   [Full Text] [Related]  

  • 2. The case against extended lymph-node dissection for prostate cancer.
    Huland H
    Nat Clin Pract Urol; 2006 Sep; 3(9):456-7. PubMed ID: 16964181
    [No Abstract]   [Full Text] [Related]  

  • 3. Laparoscopic extended pelvic lymph node dissection for high-risk prostate cancer.
    Wyler SF; Sulser T; Seifert HH; Ruszat R; Forster TH; Gasser TC; Bachmann A
    Urology; 2006 Oct; 68(4):883-7. PubMed ID: 17070376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients.
    Weckermann D; Dorn R; Trefz M; Wagner T; Wawroschek F; Harzmann R
    J Urol; 2007 Mar; 177(3):916-20. PubMed ID: 17296375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited pelvic lymph node dissection at the time of radical prostatectomy does not affect 5-year failure rates for low, intermediate and high risk prostate cancer: results from CaPSURE.
    Berglund RK; Sadetsky N; DuChane J; Carroll PR; Klein EA
    J Urol; 2007 Feb; 177(2):526-29; discussion 529-30. PubMed ID: 17222625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing patterns of pelvic lymphadenectomy for prostate cancer: results from CaPSURE.
    Kawakami J; Meng MV; Sadetsky N; Latini DM; Duchane J; Carroll PR;
    J Urol; 2006 Oct; 176(4 Pt 1):1382-6. PubMed ID: 16952638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is pelvic lymphadenectomy really necessary in patients with a serum prostate-specific antigen level of <10 ng/ml undergoing radical prostatectomy for prostate cancer?
    Burkhard FC; Schumacher M; Thalmann GN; Studer UE
    BJU Int; 2005 Feb; 95(3):275-8. PubMed ID: 15679776
    [No Abstract]   [Full Text] [Related]  

  • 8. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
    Magheli A; Rais-Bahrami S; Peck HJ; Walsh PC; Epstein JI; Trock BJ; Gonzalgo ML
    J Urol; 2007 Oct; 178(4 Pt 1):1311-5. PubMed ID: 17698095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results.
    Maffezzini M
    J Urol; 2005 Sep; 174(3):1151-2; author reply 1152. PubMed ID: 16094087
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial comment on: Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.
    Vickers AJ
    Eur Urol; 2008 Oct; 54(4):802-3. PubMed ID: 18514384
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial comment on: Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.
    Shariat SF
    Eur Urol; 2008 Oct; 54(4):803-4. PubMed ID: 18514382
    [No Abstract]   [Full Text] [Related]  

  • 12. [Radical perineal prostatectomy].
    Fichtner J; Stackl W; Thüroff JW
    Aktuelle Urol; 2008 Sep; 39(5):381-94. PubMed ID: 18798129
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of pelvic lymphadenectomy for prostate cancer--therapeutic?
    Wagner M; Sokoloff M; Daneshmand S
    J Urol; 2008 Feb; 179(2):408-13. PubMed ID: 18076938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is radiotherapy useful in node-positive prostate cancer patients after radical prostatectomy?
    Van Poppel H
    Eur Urol; 2009 May; 55(5):1012-3. PubMed ID: 19261377
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.
    Briganti A; Capitanio U; Chun FK; Gallina A; Suardi N; Salonia A; Da Pozzo LF; Colombo R; Di Girolamo V; Bertini R; Guazzoni G; Karakiewicz PI; Montorsi F; Rigatti P
    Eur Urol; 2008 Oct; 54(4):794-802. PubMed ID: 18514383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Alberto Briganti, Umberto Capitanio, Felix K.-H. Chun, et al. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer. Eur Urol 2008;54:794-804.
    Bogdanovic J; Sekulic V
    Eur Urol; 2008 Oct; 54(4):955-6. PubMed ID: 18687518
    [No Abstract]   [Full Text] [Related]  

  • 18. Laparoscopic extended pelvic lymph node dissection for prostate cancer: description of the surgical technique and initial results.
    Lattouf JB; Beri A; Jeschke S; Sega W; Leeb K; Janetschek G
    Eur Urol; 2007 Nov; 52(5):1347-55. PubMed ID: 17507150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
    Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML
    J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection.
    Briganti A; Karakiewicz PI; Chun FK; Suardi N; Gallina A; Abdollah F; Freschi M; Doglioni C; Rigatti P; Montorsi F
    Int J Urol; 2009 Aug; 16(8):676-81. PubMed ID: 19602006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.